Načítá se...
Validating α-particle emission from (211)At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors
Recently, (211)At has received increasing attention as a potential radionuclide for cancer radioimmunotherapy. It is a α-particle emitter, which is extremely effective against malignant cells. We demonstrate a method to verify the efficiency of (211)At-labeled trastuzumab antibodies ((211)At-trastuz...
Uloženo v:
| Vydáno v: | PLoS One |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5489156/ https://ncbi.nlm.nih.gov/pubmed/28658304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0178472 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|